참고문헌 (50)

1. N. Engl. J. Med. Angulo 346 1221 2002 10.1056/NEJMra011775 Nonalcoholic fatty liver disease 

   상세보기

2. Nat. Med. Cai 11 183 2005 10.1038/nm1166 Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB 

   상세보기

3. Clin. Gastroenterol. Hepatol. Charlton 2 1048 2004 10.1016/S1542-3565(04)00440-9 Nonalcoholic fatty liver disease: a review of current understanding and future impact 

   상세보기

4. Hepatology Chatzigeorgiou 60 1196 2014 10.1002/hep.27233 Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation 

   상세보기

5. Mol. Interv. Das 6 36 2006 10.1124/mi.6.1.7 Resveratrol in cardioprotection: a therapeutic promise of alternative medicine 

   상세보기

6. Gastroenterology Day 114 842 1998 10.1016/S0016-5085(98)70599-2 Steatohepatitis: a tale of two “hits”? 

   상세보기

7. J. Clin. Invest. Donnelly 115 1343 2005 10.1172/JCI23621 Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease 

   상세보기

8. QJM Dowman 103 71 2010 10.1093/qjmed/hcp158 Pathogenesis of non-alcoholic fatty liver disease 

   상세보기

9. Hepatology Fabbrini 51 679 2010 10.1002/hep.23280 Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications 

   상세보기

10. Heo, J., 2004. The Dongui Bogam, Namsandang, Seoul, Korea. 

11. J. Clin. Invest. Horton 101 2331 1998 10.1172/JCI2961 Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2 

    상세보기

12. 10.1007/BF01070758 Hoyumpa, A.M. Jr., Greene, H.L., Dunn, G.D., Schenker, S., 1975. Fatty liver: biochemical and clinical considerations. Am. J. Dig. Dis. 20, 1142-1170. 

    상세보기

13. Hepatology Ip 38 123 2003 10.1053/jhep.2003.50307 Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice 

    상세보기

14. Hepatology Ip 39 1286 2004 10.1002/hep.20170 Administration of the potent PPARalpha agonist, Wy-14.643, reverses nutritional fibrosis and steatohepatitis in mice 

    상세보기

15. J. Agric. Food Chem. Jayaprakasha 50 3668 2002 10.1021/jf025506a Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin 

    상세보기

16. Metabolism Jeong 53 607 2004 10.1016/j.metabol.2003.12.010 Fenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice 

    상세보기

17. Exp. Mol. Med. Jeong 41 397 2009 10.3858/emm.2009.41.6.045 Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice 

    상세보기

18. J. Ethnopharmacol. Jeong 119 245 2008 10.1016/j.jep.2008.06.037 The Korean traditional medicine Gyeongshingangjeehwan inhibits obesity through the regulation of leptin and PPARalpha action in OLETF rats 

    상세보기

19. Diabetes Kawano 41 1422 1992 10.2337/diab.41.11.1422 Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain 

    상세보기

20. Hepatology Kleiner 41 1313 2005 10.1002/hep.20701 Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease 

    상세보기

21. J. Chem. Pharm. Res. Ko 7 234 2015 Oregonin from the stems and leaves of Korean Alnus species (Betulaceae) 

22. Eur. J. Pharmacol. Kurita 588 316 2008 10.1016/j.ejphar.2008.04.028 Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects 

    상세보기

23. Korean Soc. Orient. Pathol. Lee 27 99 2013 Gambigyeongsinhwan (4) reduces body weight and hepatic lipid accumulation in high fat diet-fed obese male C57BL/6N mice 

24. Lee 1996 Korean Folk Medicine 

25. Li 2006 LI Dong Yuan Medical Encyclopedia 

26. Hepatology Marchesini 37 917 2003 10.1053/jhep.2003.50161 Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome 

    상세보기

27. Dev. Psychobiol. Moran 48 360 2006 10.1002/dev.20149 Hyperphagia and obesity of OLETF rats lacking CCK1 receptors: developmental aspects 

    상세보기

28. Prog. Lipid Res. Musso 48 1 2009 10.1016/j.plipres.2008.08.001 Recent insights into hepatic lipid metabolism in nonalcoholic fatty liver disease (NAFLD) 

    상세보기

29. Toxicology Ozer 245 194 2008 10.1016/j.tox.2007.11.021 The current state of serum biomarkers of hepatotoxicity 

    상세보기

30. Korean J. Orient. Med. Paik 33 33 2012 The effects in metabolism and adipose tissue imflammation induced by the Massa Medica Fermentata on obese type 2 diabetes mouse model 

31. Gastroenterology Parekh 132 2191 2007 10.1053/j.gastro.2007.03.055 Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease 

    상세보기

32. Br. J. Nutr. Parks 87 S247 2002 10.1079/BJN/2002544 Dietary carbohydrate's effects on lipogenesis and the relationship of lipogenesis to blood insulin and glucose concentrations 

    상세보기

33. Clin. Sci. Preiss 115 141 2008 10.1042/CS20070402 Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations 

    상세보기

34. Am. J. Physiol. Gastrointest. Liver. Physiol. Reddy 290 G852 2006 10.1152/ajpgi.00521.2005 Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation 

    상세보기

35. J. Ethnopharmacol. Roh 171 287 2015 10.1016/j.jep.2015.05.056 Herbal composition Gambigyeongsinhwan (4) from Curcuma longa, Alnus japonica, and Massa Medicata Fermentata inhibits lipid accumulation in 3T3-L1 cells and regulates obesity in Otsuka Long­Evans Tokushima fatty rats 

    상세보기

36. J. Altern. Complement. Med. Sharpe 13 217 2007 10.1089/acm.2006.6129 Use of complementary and alternative medicine for weight control in the United States 

    상세보기

37. J. Clin. Invest. Shimano 99 846 1997 10.1172/JCI119248 Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells 

    상세보기

38. J. Ethnopharmacol. Shin 127 47 2010 10.1016/j.jep.2009.09.052 The Korean traditional medicine gyeongshingangjeehwan inhibits adipocyte hypertrophy and visceral adipose tissue accumulation by activating PPARalpha actions in rat white adipose tissues 

    상세보기

39. Pharm. Biol. Shin 50 1261 2012 10.3109/13880209.2012.666982 The herbal composition GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits high-fat diet-induced hepatic steatosis via hepatic PPARα activation 

    상세보기

40. N. Engl. J. Med. Shulman 353 604 2005 10.1056/NEJMra043590 Retinoid X receptor heterodimers in the metabolic syndrome 

    상세보기

41. Gene Takiguchi 197 169 1997 10.1016/S0378-1119(97)00259-X Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats 

    상세보기

42. Trends Endocrinol. Metab. Tilg 19 371 2008 10.1016/j.tem.2008.08.005 Insulin resistance, inflammation, and non-alcoholic fatty liver disease 

    상세보기

43. Basic. Clin. Pharmacol. Toxicol. Um 3 152 2013 10.1111/bcpt.12076 Curcumin attenuates diet-induced hepatic steatosis by activating AMP-activated protein kinase 

    상세보기

44. Methods Find. Exp. Clin. Pharmacol. Valcheva-Kuzmanova 29 101 2007 10.1358/mf.2007.29.2.1075349 Hypoglycemic and hypolipidemic effects of Aronia melanocarpa fruit juice in streptozotocin-induced diabetic rats 

    상세보기

45. Hepatology Vuppalanchi 49 306 2009 10.1002/hep.22603 Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management 

    상세보기

46. Hepatology Yamaguchi 45 1366 2007 10.1002/hep.21655 Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis 

    상세보기

47. Curr. Diabetes Rep. Yki-Jarvinen 7 173 2007 10.1007/s11892-007-0028-0 ADOPT: Lessons from comparison of glycemic durability of rosiglitazone, metformin, or glyburide monotherapy 

    상세보기

48. Pharmacol. Res. Yoon 60 151 2009 10.1016/j.phrs.2009.02.004 The role of PPARα in lipid metabolism and obesity: focusing on the effects of estrogen on PPARα actions 

    상세보기

49. PPAR Res. Yoon 2010 584296. 2010 10.1155/2010/584296 PPARα in obesity: sex difference and estrogen involvement 

    상세보기

50. Yakhak Hoeji Zhao 56 99 2012 Hepatoprotective effects of Alnus japonica extract on experimental liver injury model